Multivalent Influenza Vaccines

Abstract: Provided are octavalent influenza vaccine compositions comprising eight mRNA, each mRNA comprising an open reading frame encoding a different influenza antigen. Also provided are lipid nanoparticles (LNPs) for delivering said mRNA.

Patent Information

Application #

Filing Date

06 December 2023

Publication Number

39/2024

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

SANOFI

46 avenue de la Grande Armée 75017 Paris

Inventors

1. ALEFANTIS, Timothy

c/o Sanofi, Patent Department 50 Binney Street Cambridge, Massachusetts 02142

2. CHIVUKULA, Sudha

c/o Sanofi, Patent Department 50 Binney Street Cambridge, Massachusetts 02142

Specification

Documents

Application Documents

#	Name	Date
1	202317083196-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [06-12-2023(online)].pdf	2023-12-06
2	202317083196-STATEMENT OF UNDERTAKING (FORM 3) [06-12-2023(online)].pdf	2023-12-06
3	202317083196-Sequence Listing in txt [06-12-2023(online)].txt	2023-12-06
4	202317083196-Sequence Listing in PDF [06-12-2023(online)].pdf	2023-12-06
5	202317083196-FORM 1 [06-12-2023(online)].pdf	2023-12-06
6	202317083196-DRAWINGS [06-12-2023(online)].pdf	2023-12-06
7	202317083196-DECLARATION OF INVENTORSHIP (FORM 5) [06-12-2023(online)].pdf	2023-12-06
8	202317083196-COMPLETE SPECIFICATION [06-12-2023(online)].pdf	2023-12-06
9	202317083196-FORM-26 [09-02-2024(online)].pdf	2024-02-09
10	202317083196-FORM 3 [28-05-2024(online)].pdf	2024-05-28
11	202317083196-Proof of Right [20-01-2025(online)].pdf	2025-01-20
12	202317083196-PA [27-05-2025(online)].pdf	2025-05-27
13	202317083196-ASSIGNMENT DOCUMENTS [27-05-2025(online)].pdf	2025-05-27
14	202317083196-8(i)-Substitution-Change Of Applicant - Form 6 [27-05-2025(online)].pdf	2025-05-27
15	202317083196-FORM 18 [10-06-2025(online)].pdf	2025-06-10